НЕЙРОИНДУЦИРОВАННЫЕ МЕЗЕНХИМАЛЬНЫЕ СТВОЛОВЫЕ КЛЕТКИ В ТЕРАПИИ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТЕМЫ
Мезенхимальные стволовые клетки (МСК) рассматриваются как перспективный терапевтический агент при ряде заболеваний, включая неизлечимые патологии нервной системы. В данном обзоре обсуждается терапевтическое применение МСК, подвергнутых дифференцировке в неконвенционном нейрогенном направлении. Проведен анализ данных по нейродифференцировке МСК в культуре in vitro, результатов исследований на подопытных животных, а также последних данных клинических испытаний нейродифференцированных МСК в Беларуси и за рубежом для лечения пациентов с диагнозами «боковой амиотрофический склероз» и «эпилепсия».
1. Bjorklund, A. Neurobiology. Better cells for brain repair / A. Bjorklund // Nature. – 1993. – Vol. 362. – P. 414–415.
2. Autologous mesenchymal stem cell transplantation in stroke patients / O. Y. Bang [et al.] // Ann. Neurol. – 2005. – Vol. 57. – P. 874–882.
3. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium / D. G. Katritsis [et al.] // Catheter. Cardiovasc. Interv. – 2005. – Vol. 65. – P. 321–329.
4. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) / O. N. Koc [et al.] // Bone Marrow Transplant. – 2002. – Vol. 30. – P. 215–222.
5. Fibroblast precursors in normal and irradiated mouse hematopoietic organs / A. J. Friedenstein [et al.] // Exp. Hematol. – 1976. – Vol. 4. – P. 267–274.
6. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition / N. R. Blondheim [et al.] // Stem Cells Dev. – 2006. – Vol. 15. – P. 141–164.
7. Xenograft of human umbilical mesenchymal stem cells from Wharton’s jelly as a potential therapy for rat pilocarpineinduced epilepsy / P. Y. Huang [et al.] // Brain Behav. Immun. – 2015.
8. Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord / C. C. Yang [et al.] // PLoS. One. – 2008. – Vol. 3. – P. e3336.
9. The imbalanced expression of adenosine receptors in an epilepsy model corrected using targeted mesenchymal stem cell transplantation / K. Huicong [et al.] // Mol. Neurobiol. – 2013. – Vol. 48. – P. 921–930.
10. Early transplantation of bone marrow mononuclear cells promotes neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine mechanisms / M. M. Leal [et al.] // Neurochem. Res. – 2014. – Vol. 39. – P. 259– 268.
11. Prevention of seizures and reorganization of hippocampal functions by transplantation of bone marrow cells in the acute phase of experimental epilepsy / Z. S. Costa-Ferro [et al.] // Seizure. – 2010. – Vol. 19. – P. 84–92.
12. Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats / Z. S. Costa-Ferro [et al.] // Neurobiol. Dis. – 2012. – Vol. 46. – P. 302–313.
13. Antiepileptic and neuroprotective effects of human umbilical cord blood mononuclear cells in a pilocarpine-induced epilepsy model / Z. S. Costa-Ferro [et al.] // Cytotechnology. – 2014. – Vol. 66. – P. 193–199.
14. Trans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegiline / A. Abdanipour [et al.] // Iran Biomed. J. – 2011. – Vol. 15. – P. 113–121.
15. Genetically engineered bone marrow mesenchymal stem cells improve functional outcome in a rat model of epilepsy / Q. Long [et al.] // Brain Res. – 2013. – Vol. 1532. – P. 1–13.
16. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis / C. Boucherie [et al.] // J. Neurosci. Res. – 2009. – Vol. 87. – P. 2034– 2046.
17. Long-term survival in amyotrophic lateral sclerosis: a population-based study / E. Pupillo [et al.] // Ann. Neurol. – 2014. – Vol. 75. – P. 287–297.
18. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study / A. Al-Chalabi [et al.] // Lancet Neurol. – 2014. – Vol. 13. – P. 1108–1113.
19. Cell-replacement therapy with stem cells in neurodegenerative diseases / V. Silani [et al.] // Curr. Neurovasc. Res. – 2004. – Vol. 1. – P. 283–289.
20. The past, present and future of stem cell clinical trials for ALS / G. M. Thomsen [et al.] // Exp. Neurol. – 2014. – Vol. 262. – Pt B. – P. 127–137.
21. Transplantation of mesenchymal stem cells in ALS / L. Mazzini [et al.] // Prog. Brain Res. – 2012. – Vol. 201. – P. 333–359.
22. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells / C. Nicaise [et al.] // Neuropathol. Appl. Neurobiol. – 2011. – Vol. 37. – P. 179–188.
23. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis / A. Uccelli [et al.] // Mol. Med. – 2012. – Vol. 18. – P. 794–804.
24. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis / A. Vercelli [et al.] // Neurobiol. Dis. – 2008. – Vol. 31. – P. 395–405.
25. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis / S. Forostyak [et al.] // Cytotherapy. – 2011. – Vol. 13. – P. 1036–1046.
26. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice / C. P. Zhao [et al.] // Cytotherapy. – 2007. – Vol. 9. – P. 414–426.
27. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis / M. Boido [et al.] // Cytotherapy. – 2014. – Vol. 16. – P. 1059–1072.
28. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats / L. Xu [et al.] // Neurosci. Lett. – 2011. – Vol. 494. – P. 222–226.
29. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis / S. Garbuzova-Davis [et al.] // Exp. Neurol. – 2002. – Vol. 174. – P. 169–180.
30. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis / R. Hemendinger [et al.] // Exp. Neurol. – 2005. – Vol. 196. – P. 235–243.
31. Improvement of the pilocarpine epilepsy model in rat using bone marrow stromal cell therapy / A. Abdanipour [et al.] // Neurol. Res. – 2011. – Vol. 33. – P. 625–632.
32. Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy / S. Agadi [et al.] // Stem Cells. – 2015. – Vol. 33. – P. 2093–2103.
33. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function / A. Voulgari-Kokota [et al.] // Exp. Neurol. – 2012. – Vol. 236. – P. 161–170.
34. Epilepsy: Novel therapeutic targets / A. P. Anovadiya [et al.] // J. Pharmacol. harmacother. – 2012. – Vol. 3. – P. 112–117.
35. Stem cell treatment in Amyotrophic Lateral Sclerosis / L. Mazzini [et al.] // J. Neurol. Sci. – 2008. – Vol. 265. – P. 78–83.
36. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study / L. Mazzini [et al.] // Cytotherapy. – 2012. – Vol. 14. – P. 56–60.
37. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis / D. Karussis [et al.] // Arch. Neurol. – 2010. – Vol. 67. – P. 1187–1194.
38. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study / M. Blanquer [et al.] // Stem Cells. – 2012. – Vol. 30. – P. 1277–1285.
39. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis / K. W. Oh [et al.] // Stem Cells Transl. Med. – 2015. – Vol. 4. – P. 590–597.
40. Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging / O. Sadan [et al.] // Stem Cells. – 2008. – Vol. 26. – P. 2542–2551.
41. Differentiated mesenchymal stem cells for sciatic nerve injury / M. Dadon-Nachum [et al.] // Stem Cell Rev. – 2011. – Vol. 7. – P. 664–671.
42. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells / A. Hermann [et al.] // J. Cell Sci. – 2004. – Vol. 117. – P. 4411–4422.
43. Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells / S. Kim [et al.] // Brain Res. – 2006. – Vol. 1123. – P. 27–33.
44. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells / X. Long [et al.] // Stem Cells Dev. – 2005. – Vol. 14. – P. 65–69.
45. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? / P. Lu [et al.] // J. Neurosci. Res. – 2004. – Vol. 77. – P. 174–191.
46. Adult bone marrow stromal cells differentiate into neural cells in vitro / J. Sanchez Ramos [et al.] // Exp. Neurol. – 2000. – Vol. 164. – P. 247–256.
47. Adult rat and human bone marrow stromal cells differentiate into neurons / D. Woodbury [et al.] // J. Neurosci. Res. – 2000. – Vol. 61. – P. 364–370.
48. Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K+ channel types / K. Mareschi [et al.] // Exp. Hematol. – 2006. – Vol. 34. – P. 1563–1572.
49. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos / C. D. Keene [et al.] // Cell Transplant. – 2003. – Vol. 12. – P. 201–213.
50. Neural induction of adult bone marrow and umbilical cord stem cells / X. R. Ortiz- Honzalez [et al.] // Curr. Neurovasc. Res. – 2004. – Vol. 1. – P. 207–213.
51. Plasticity of human mesenchymal stem cell phenotype and expression profile under neurogenic conditions / A. V. Shakhbazau [et al.] // Bull. Exp. Biol. Med. – 2009. – Vol. 147. – P. 513–516.
52. Neurogenic induction of human mesenchymal stem cells in fibrin 3D matrix / A. V. Shakhbazau [et al.] // Bull. Exp. Biol. Med. – 2011. – Vol. 150. – P. 547–550.
53. Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: progress and uncertainties / Y. Chen [et al.] // Cell Mol. Life Sci. – 2006. – Vol. 63. – P. 1649–1657.
54. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray / N. Bertani [et al.] // J. Cell Sci. – 2005. – Vol. 118. – P. 3925–3936.
55. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation / J. Deng [et al.] // Stem Cells. – 2006. – Vol. 24. – P. 1054– 1064.
56. Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells / T. Tondreau [et al.] // BMC. Genomics. – 2008. – Vol. 9. – P. 166.
57. The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC) – a preliminary study using microarray analysis / S. Yamaguchi [et al.] // Brain Res. – 2006. – Vol. 1087. – P. 15–27.
58. Matrix elasticity directs stem cell lineage specification / A. J. Engler [et al.] // Cell. – 2006. – Vol. 126. – P. 677–689.
59. Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering / G. Jin [et al.] // Acta Biomater. – 2011. – Vol. 7. – P. 3113–3122. 60. Biodegradable fibrous scaffolds with tunable properties formed from photo-cross- inkable poly(glycerol sebacate) / J. Ifkovits L. [et al.] // ACS Appl. Mater. Interfaces. – 2009. – Vol. 1. – P. 1878–1886.
60. Engineered microenvironments for controlled stem cell differentiation / J. A. Burdick [et al.] // Tissue Eng Part A. – 2009. – Vol. 15. – P. 205–219.
61. Vascular differentiation of bone marrow stem cells is directed by a tunable three- dimensional matrix / G. Zhang [et al.] // Acta Biomater. – 2010. – Vol. 6. – P. 3395–3403.
62. Extracellular matrix elasticity directs stem cell differentiation / A. J. Engler [et al.] // J. Musculoskelet. Neuronal. Interact. – 2007. – Vol. 7. – P. 335.
63. Induction of pluripotent stem cells from adult human fibroblasts by defined factors / K. Takahashi [et al.] // Cell. – 2007. – Vol. 131. – P. 861–872.
64. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation / M. Dezawa [et al.] // J. Clin. Invest. – 2004. – Vol. 113. – P. 1701–1710.
65. Brain from bone: efficient “meta-differentiation” of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent / J. Kohyama [et al.] // Differentiation. – 2001. – Vol. 68. – P. 235–244.
66. Modification of the brain-derived neurotrophic factor gene: a portal to transform mesenchymal stem cells into advantageous engineering cells for neuroregeneration and neuroprotection / L. X. Zhao [et al.] // Exp. Neurol. – 2004. – Vol. 190. – P. 396–406.
67. Combination of adenoviral vector-mediated neurotrophin-3 gene transfer and retinoic acid promotes adult bone marrow cells to differentiate into neuronal phenotypes / W. Zhang [et al.] // Neurosci. Lett. – 2006. – Vol. 408. – P. 98–103.
68. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene / J. E. LeCouter [et al.] // Development. – 1998. – Vol. 125. – P. 4669–4679.
69. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis / E. Y. Lee [et al.] // Nature. – 1992. – Vol. 359. – P. 288–294.